Robotic Surgery for Rectal Cancer: Operative Technique and Review of the Literature
-
- Katsuno Hidetoshi
- Department of Surgery, Fujita Health University, School of Medicine
-
- Hanai Tsunekazu
- Department of Surgery, Fujita Health University, School of Medicine
-
- Masumori Koji
- Department of Surgery, Fujita Health University, School of Medicine
-
- Koide Yoshikazu
- Department of Surgery, Fujita Health University, School of Medicine
-
- Ashida Keigo
- Department of Surgery, Fujita Health University, School of Medicine
-
- Matsuoka Hiroshi
- Department of Surgery, Fujita Health University, School of Medicine
-
- Tajima Yosuke
- Department of Surgery, Fujita Health University, School of Medicine
-
- Endo Tomoyoshi
- Department of Surgery, Fujita Health University, School of Medicine
-
- Mizuno Masahiro
- Department of Surgery, Fujita Health University, School of Medicine
-
- Cheong Yeongcheol
- Department of Surgery, Fujita Health University, School of Medicine
-
- Maeda Kotaro
- International Medical Center, Fujita Health University Hospital
-
- Uyama Ichiro
- Department of Surgery, Fujita Health University, School of Medicine
説明
<p>The number of patients undergoing robotic surgery for rectal cancer has rapidly increased in Japan, since the government approved the procedure for national insurance coverage in April 2018. Robotic surgery has the potential to overcome some limitations of laparoscopic surgery, especially in the narrow pelvis, providing a three-dimensional view, articulated instruments, and a stable camera platform. Although meta-analyses and randomized controlled trials have failed to demonstrate the superiority of robotic surgery over laparoscopic surgery with respect to the short-term clinical outcomes, the published findings suggest that robotic surgery may be potentially beneficial for patients who are obese, male, or patients undergoing sphincter-preserving surgery for rectal cancer. The safety and feasibility of robotic surgery for lateral lymph node dissection, the standard procedure for locally advanced lower rectal cancer in Japan, have been demonstrated in some retrospective studies. However, additional prospective, randomized trials are required to determine the actual benefits of robotic surgery to ameliorate the urogenital and oncological outcomes. The cost of this approach is a long-standing principal concern. A literature search showed that the cost of robotic surgery for rectal cancer was 1.3-2.5 times higher per patient than that for the laparoscopic approach. We herein describe our surgical technique using a da Vinci Surgical System (S/Si/Xi) with 10 years of experience in performing robotic surgery. We also review current evidence regarding short-term clinical and long-term oncological outcomes, lateral lymph node dissection, and the cost of the procedure.</p>
収録刊行物
-
- Journal of the Anus, Rectum and Colon
-
Journal of the Anus, Rectum and Colon 4 (1), 14-24, 2020-01-30
一般社団法人日本大腸肛門病学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390565134823944704
-
- NII論文ID
- 130007792317
-
- ISSN
- 24323853
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可